261 related articles for article (PubMed ID: 31392677)
1. Microglia in Neurodegenerative Disorders.
Tejera D; Heneka MT
Methods Mol Biol; 2019; 2034():57-67. PubMed ID: 31392677
[TBL] [Abstract][Full Text] [Related]
2. Role of Microglia in Modulating Adult Neurogenesis in Health and Neurodegeneration.
Al-Onaizi M; Al-Khalifah A; Qasem D; ElAli A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961703
[TBL] [Abstract][Full Text] [Related]
3. Let's make microglia great again in neurodegenerative disorders.
Guillot-Sestier MV; Town T
J Neural Transm (Vienna); 2018 May; 125(5):751-770. PubMed ID: 29027011
[TBL] [Abstract][Full Text] [Related]
4. Microglia-Specific Metabolic Changes in Neurodegeneration.
Aldana BI
J Mol Biol; 2019 Apr; 431(9):1830-1842. PubMed ID: 30878483
[TBL] [Abstract][Full Text] [Related]
5. Inflammasomes in neuroinflammatory and neurodegenerative diseases.
Voet S; Srinivasan S; Lamkanfi M; van Loo G
EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31015277
[TBL] [Abstract][Full Text] [Related]
6. Differential contribution of microglia and monocytes in neurodegenerative diseases.
Baufeld C; O'Loughlin E; Calcagno N; Madore C; Butovsky O
J Neural Transm (Vienna); 2018 May; 125(5):809-826. PubMed ID: 29063348
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Osteopontin on Microglia.
Yu H; Liu X; Zhong Y
Biomed Res Int; 2017; 2017():1879437. PubMed ID: 28698867
[TBL] [Abstract][Full Text] [Related]
8. Microglial-neuronal interactions during neurodegenerative diseases.
Colton CA
J Neuroimmune Pharmacol; 2013 Mar; 8(1):4-6. PubMed ID: 23404094
[TBL] [Abstract][Full Text] [Related]
9. Brain-Resident Microglia and Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation in Neurodegenerative Disorders and Brain Cancer.
Sevenich L
Front Immunol; 2018; 9():697. PubMed ID: 29681904
[TBL] [Abstract][Full Text] [Related]
10. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.
Walker DG; Lue LF
Alzheimers Res Ther; 2015 Aug; 7(1):56. PubMed ID: 26286145
[TBL] [Abstract][Full Text] [Related]
11. TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
Papageorgiou IE; Lewen A; Galow LV; Cesetti T; Scheffel J; Regen T; Hanisch UK; Kann O
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):212-7. PubMed ID: 26699475
[TBL] [Abstract][Full Text] [Related]
12. Dual role of histamine on microglia-induced neurodegeneration.
Barata-Antunes S; Cristóvão AC; Pires J; Rocha SM; Bernardino L
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):764-769. PubMed ID: 28057587
[TBL] [Abstract][Full Text] [Related]
13. Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms.
Sabogal-Guáqueta AM; Marmolejo-Garza A; de Pádua VP; Eggen B; Boddeke E; Dolga AM
Prog Neurobiol; 2020 Jul; 190():101805. PubMed ID: 32335273
[TBL] [Abstract][Full Text] [Related]
14. A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases.
Kaushik DK; Basu A
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):726-40. PubMed ID: 24070095
[TBL] [Abstract][Full Text] [Related]
15. Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
Giunti D; Parodi B; Cordano C; Uccelli A; Kerlero de Rosbo N
Immunology; 2014 Mar; 141(3):328-39. PubMed ID: 24116890
[TBL] [Abstract][Full Text] [Related]
16. Microglia activation states and cannabinoid system: Therapeutic implications.
Mecha M; Carrillo-Salinas FJ; Feliú A; Mestre L; Guaza C
Pharmacol Ther; 2016 Oct; 166():40-55. PubMed ID: 27373505
[TBL] [Abstract][Full Text] [Related]
17. Microglial cell origin and phenotypes in health and disease.
Saijo K; Glass CK
Nat Rev Immunol; 2011 Oct; 11(11):775-87. PubMed ID: 22025055
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors in neurodegeneration.
Owens T
Curr Top Microbiol Immunol; 2009; 336():105-20. PubMed ID: 19688330
[TBL] [Abstract][Full Text] [Related]
19. Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models.
Sugama S; Takenouchi T; Cho BP; Joh TH; Hashimoto M; Kitani H
Inflamm Allergy Drug Targets; 2009 Sep; 8(4):277-84. PubMed ID: 19754411
[TBL] [Abstract][Full Text] [Related]
20. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia.
Lehnardt S; Henneke P; Lien E; Kasper DL; Volpe JJ; Bechmann I; Nitsch R; Weber JR; Golenbock DT; Vartanian T
J Immunol; 2006 Jul; 177(1):583-92. PubMed ID: 16785556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
